
Cardiologist

No OPD information available
Hypertension
Arteriovenous Malformation
Cataract
Cataract Removal
Ehlers-Danlos Syndrome (EDS)
Hydrocephalus
Polycystic Kidney Disease
Postural Orthostatic Tachycardia Syndrome (POTS)
Vasoconstriction
Mark Butlin is a male healthcare provider who helps patients with different health issues like high blood pressure, abnormal blood vessel connections, cloudy eye lenses, eye surgery, a rare genetic disorder affecting skin and joints, excess fluid in the brain, a kidney condition with cysts, a condition affecting heart rate and blood flow, and blood vessel narrowing.
Mark Butlin uses special skills and treatments to care for patients with these conditions. He talks to patients in a way that makes them feel comfortable and safe, which helps patients trust him. Patients appreciate Mark Butlin's ability to explain things clearly and answer their questions.
To stay updated with new medical information, Mark Butlin reads research articles and attends conferences. This helps him provide the best care for his patients. Mark Butlin works well with other medical professionals, sharing knowledge and collaborating to give patients the best treatment.
Mark Butlin's work has had a positive impact on many patients' lives. For example, he has improved the quality of life for people with chronic health conditions. His research on pulse wave velocity and participation in clinical trials show his dedication to advancing medical knowledge and improving patient care.
One of Mark Butlin's notable publications is a study on computerized algorithms for measuring pulse wave velocity. He has also been involved in a clinical trial focusing on monitoring blood pressure and artery stiffness remotely. These contributions show his commitment to advancing healthcare practices.
In summary, Mark Butlin is a caring and knowledgeable healthcare provider who uses his skills and expertise to help patients with various health conditions. He stays informed about the latest medical research, collaborates with colleagues, and makes a positive impact on patients' lives through his work and research efforts.
Enrollment Status: Completed
Published: December 16, 2024
Intervention Type: Device
Study Drug:
Study Phase:
